(ACIU) AC Immune - Performance -47.8% in 12m
ACIU performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-80.46%
#133 in Peer-Group
Rel. Strength
9.59%
#6971 in Stock-Universe
Total Return 12m
-47.80%
#126 in Peer-Group
Total Return 5y
-70.60%
#81 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 11.2 |
| High / Low | USD |
|---|---|
| 52 Week High | 4.20 USD |
| 52 Week Low | 1.48 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 77.29 |
| Buy/Sell Signal +-5 | 0.48 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ACIU (-47.8%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ACIU vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ACIU
| Total Return (including Dividends) | ACIU | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 22.80% | 4.38% | 4.99% |
| 3 Months | 7.45% | 5.22% | 10.23% |
| 12 Months | -47.80% | -7.16% | 14.42% |
| 5 Years | -70.60% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | ACIU | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 20.9% | 3.5% | 79.1% |
| 3 Months | 74% | 75.7% | 95.5% |
| 12 Months | -92.1% | -85.1% | 44.7% |
| 5 Years | -73.1% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th86.00 | 17.65% | 16.96% |
| 3 Month | %th53.50 | 2.12% | -2.53% |
| 12 Month | %th37.50 | -43.78% | -54.38% |
| 5 Years | %th60.00 | -61.00% | -86.01% |
FAQs
Does AC Immune (ACIU) outperform the market?
No,
over the last 12 months ACIU made -47.80%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months ACIU made 7.45%, while XBI made 5.22%.
Performance Comparison ACIU vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ACIU vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.6% | 17.8% | -35.9% | -62% |
| US NASDAQ 100 | QQQ | -4.2% | 17.4% | -37.4% | -62% |
| German DAX 40 | DAX | -3.6% | 23.4% | -47.4% | -78% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.9% | 18.6% | -36.3% | -65% |
| Hongkong Hang Seng | HSI | -2.7% | 15.7% | -54.4% | -85% |
| India NIFTY 50 | INDA | -3.5% | 20.9% | -33.2% | -48% |
| Brasil Bovespa | EWZ | -7.3% | 14.8% | -58.8% | -61% |
ACIU vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.6% | 17.1% | -40.2% | -74% |
| Consumer Discretionary | XLY | -5.7% | 19.9% | -29% | -67% |
| Consumer Staples | XLP | -4.9% | 22.9% | -35.3% | -58% |
| Energy | XLE | -5.3% | 16.7% | -31% | -46% |
| Financial | XLF | -4.8% | 19.2% | -39% | -76% |
| Health Care | XLV | -3.5% | 20.3% | -28.3% | -43% |
| Industrial | XLI | -5.5% | 18.6% | -42.7% | -72% |
| Materials | XLB | -7.7% | 17% | -40.1% | -55% |
| Real Estate | XLRE | -3.8% | 21.9% | -34.4% | -61% |
| Technology | XLK | -4.1% | 13.8% | -38.8% | -59% |
| Utilities | XLU | -3.3% | 23.3% | -37.1% | -71% |
| Aerospace & Defense | XAR | -4.8% | 15.3% | -54.2% | -96% |
| Biotech | XBI | -4.3% | 18.4% | -21.8% | -41% |
| Homebuilder | XHB | -9.5% | 11.2% | -29.8% | -54% |
| Retail | XRT | -7.3% | 17.3% | -30.7% | -58% |
ACIU vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -5.5% | 14.1% | -27.4% | -41% |
| Natural Gas | UNG | 0.3% | 31.4% | -19.8% | -42% |
| Gold | GLD | -3.1% | 23.6% | -55.1% | -91% |
| Silver | SLV | -3.1% | 17.6% | -52.6% | -71% |
| Copper | CPER | -6.9% | 16.6% | -56.5% | -65% |
ACIU vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -2.9% | 19.6% | -31.3% | -49% |
| iShares High Yield Corp. Bond | HYG | -3.1% | 20.9% | -34% | -58% |